Loading...
Market
Will Brenus Pharma announce a partnership with a major pharmaceutical company by June 30, 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcement from Brenus Pharma or the partnering company
Story
Brenus Pharma Secures €22.2M ($25M) to Accelerate Cancer Vaccine Trials
Sep 18, 2024, 07:37 AM
Brenus Pharma, a Lyon-based biotech company specializing in the development of precision cancer vaccines, has successfully raised €22.2 million ($25 million) in a Series A funding round. The financing was led by Angelor and will be used to accelerate clinical trials of its cancer vaccines. This significant investment underscores the growing interest and support for innovative cancer treatment solutions in the biotech sector.
View original story
Similar markets
Yes • 50%
No • 50%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%